Investment Rating - The investment rating for the company is not explicitly stated in the provided documents, but the overall performance suggests a positive outlook based on significant revenue and profit growth. Core Insights - The company reported a revenue of 1.766 billion yuan in 2024, representing a year-on-year increase of 29.26%, with a net profit of 106 million yuan, up 94.58% year-on-year. In Q1 2025, revenue reached 574 million yuan, a 54.16% increase, and net profit was 27 million yuan, up 113.88% year-on-year [1][2]. - The self-owned brand business showed remarkable performance, with revenue of 500 million yuan in 2024, a 90.28% increase, accounting for 28.37% of total revenue. The brand "Zhanjia" achieved a revenue of 484 million yuan, with a 90.09% increase, and significant growth in various sales channels [2][3]. - The brand management business also demonstrated strong growth, with revenue of 501 million yuan in 2024, a 212.24% increase. Notable brands like "Kangwang" and "Aiwei Nuo" saw substantial sales growth across multiple platforms [3][4]. - The overall gross margin for the company improved to 44.57% in 2024, an increase of 4.33 percentage points year-on-year, with specific margins for different business segments showing varied performance [4]. Summary by Sections Financial Performance - In 2024, the company achieved a total revenue of 1.766 billion yuan, with a net profit of 106 million yuan, and in Q1 2025, revenue was 574 million yuan with a net profit of 27 million yuan [1]. - The proposed dividend for 2024 is 0.5 yuan per share, with a total cash dividend of 79 million yuan, resulting in a dividend payout ratio of 75.09% [1]. Brand Performance - The self-owned brand "Zhanjia" launched a strategic product and achieved significant sales growth, ranking first in Tmall's new brand sales during the Double Eleven shopping festival [2]. - The brand "Feicui" also showed rapid sales growth since its launch, ranking highly on various e-commerce platforms [2]. Business Segments - The brand management segment reported a revenue increase of 212.24% in 2024, with notable contributions from brands like "Kangwang" and "Aiwei Nuo" [3]. - Strategic partnerships with international brands were established to enhance the company's presence in the health and personal care sectors [4].
若羽臣(003010):2024、25Q1业绩持续较快增长,自有品牌表现亮眼